Report Title: The burden of liver disease in Europe: a review of available epidemiological data

By M. Blachier, H. Leleu, M. Peck‐Radosavljevic, Charles-Dominique Valla, F. Roudot-thoraval. 2013

1,356 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/5e4c188ca0117ea4579d397d3a128f2cdca7328f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Hao Chen
2. Qi-Yan Dou
3. P. Heng
4. Xiaomeng Li
5. B. van Ginneken
6. Chi-Wing Fu
7. Md. Zahangir Alom
8. Xiaojuan Qi

Citations in the corpus

• The Liver Tumor Segmentation Benchmark (LiTS) (2019, background): “Instead of measuring diameters of target lesions, a fully volumetric segmentation of both liver and its lesion and the subsequent tumor burden analysis offers valuable insights of the disease progression [15].”
• NAFLD: a multisystem disease. (2015, background): “Current populationbased prevalence of NAFLD is approximately 30–40% in men and 15–20% in women [4] and is even higher in people with type 2 diabetes mellitus (T2DM), occurring in up to 70% of this group of patients [5].”